Tubidy MP3 & MP4

En popüler MP3 müziklerinizi ve MP4 videolarınızı ücretsiz indirin. Geniş bir multimedya içeriği seçkisini keşfedin ve sorunsuz indirmelerin tadını çıkarın.

Manufacturing Process and Controls: Avoiding Assessment Issues (26of28) GDF – Apr. 3-4, 2019
Manufacturing Process and Controls: Avoiding Assessment Issues (26of28) GDF – Apr. 3-4, 2019
|
Yükleniyor...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Manufacturing Process and Controls: Avoiding Assessment Issues (26of28) GDF – Apr. 3-4, 2019

Manufacturing Process and Controls: Avoiding Assessment Issues (26of28) GDF – Apr. 3-4, 2019

|
Continuous Manufacturing with a Generic Perspective (25of28) Generic Drugs Forum – Apr. 3-4, 2019

Continuous Manufacturing with a Generic Perspective (25of28) Generic Drugs Forum – Apr. 3-4, 2019

|
Deficiencies and Observations from Facility Evaluations and Inspections(27of28) GDF – Apr. 3-4, 2019

Deficiencies and Observations from Facility Evaluations and Inspections(27of28) GDF – Apr. 3-4, 2019

|
Impurity Case Studies: Pharmacology/Toxicology (22of28) Generic Drugs Forum – Apr. 3-4, 2019

Impurity Case Studies: Pharmacology/Toxicology (22of28) Generic Drugs Forum – Apr. 3-4, 2019

|
Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018

Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018

|
Drug Master Files (DMFs) from an ANDA Perspective (7of28) Generic Drugs Forum – Apr. 3-4, 2019

Drug Master Files (DMFs) from an ANDA Perspective (7of28) Generic Drugs Forum – Apr. 3-4, 2019

|
Small Molecule Case Studies (8of33) Quality – Oct. 16-17, 2019

Small Molecule Case Studies (8of33) Quality – Oct. 16-17, 2019

|
An Overview of Pre-License Inspections for Biotech Products (5/15) Global Quality

An Overview of Pre-License Inspections for Biotech Products (5/15) Global Quality

|
Common CMC (Quality) Issues and How to Avoid Them Part II (13of16) Generic Drugs Forum 2020

Common CMC (Quality) Issues and How to Avoid Them Part II (13of16) Generic Drugs Forum 2020

|
End-to-end Integrated Continuous Manufacturing (25of33) Quality – Oct. 16-17, 2019

End-to-end Integrated Continuous Manufacturing (25of33) Quality – Oct. 16-17, 2019

|
ORA Aligned for the Future (1of15) REdI – May 29-30, 2019

ORA Aligned for the Future (1of15) REdI – May 29-30, 2019

|
Deviations Analysis for FDA Inspection? #usfda #aseptic #deviations #gmp #pharma @PHARMAVEN

Deviations Analysis for FDA Inspection? #usfda #aseptic #deviations #gmp #pharma @PHARMAVEN

|
AI in Chemical Manufacturing with Dr Lloyd Colegrove Part 1/4 | SoothSight #8 | Soothsayer Analytics

AI in Chemical Manufacturing with Dr Lloyd Colegrove Part 1/4 | SoothSight #8 | Soothsayer Analytics

|
Questions and Panel Discussion – Post-approval CMC and Manufacturing - REdI 2020

Questions and Panel Discussion – Post-approval CMC and Manufacturing - REdI 2020

|
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017

Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017

|
Pharmaceutical Quality Update by Dr. Michael Kopcha (2of27) Generic Drugs Forum April 2018

Pharmaceutical Quality Update by Dr. Michael Kopcha (2of27) Generic Drugs Forum April 2018

|
ICH M7(R1) – Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment

ICH M7(R1) – Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment

|
Process Validation and ICH Q7

Process Validation and ICH Q7

|
Pharmaceutical API manufacturing

Pharmaceutical API manufacturing

|
BIOPHARMACEUTICAL PROCESS DEVELOPMENT – TRENDS/ CHALLENGES/OPPORTUNITIES

BIOPHARMACEUTICAL PROCESS DEVELOPMENT – TRENDS/ CHALLENGES/OPPORTUNITIES

|